Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06260397
Other study ID # analgesia for MRM surgeries
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date February 28, 2024
Est. completion date March 30, 2025

Study information

Verified date January 2024
Source Ain Shams University
Contact Abdalla Magdy Abdalla, master
Phone 01002717445
Email abdalla.magdy@med.asu.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Adequate pain management following modified radical mastectomy (MRM) is crucial for early ambulation and patient satisfaction. Breast cancer is the most common malignancy in females, with an increasing incidence in recent years. Surgery is one of the mainstays of therapy for breast cancer, and modified radical mastectomy (MRM) is the most effective and common type of invasive surgical treatment. Post-mastectomy pain syndrome (PMPS) is a surgical complication of breast surgery characterized by chronic neuropathic pain. The aim of this study is to investigate the efficacy and safety of single injection CTB versus SAPB on post-operative acute pain as a part of a multimodal analgesia plan in patients undergoing MRM.


Description:

Patients will be divided randomly by the computer into three groups, group (A): will receive serratus anterior plane block, group (B): will receive costotransverse block and group(C): patient controlled analgesia group (PCA). Group (A) (SAPB): SAPB will be performed using an ultrasound machine with a high-frequency linear probe . All patients will be in lateral position to perform the block. At the level of the fourth rib with 45-degree angle, targeting the plane between the latissimus dorsi and serratus muscles, SAPB block will be performed unilaterally on the ipsilateral side of surgery. Group (B) (CTB): CTB will be performed using an ultrasound machine with a high-frequency linear probe. All patients will be in lateral position to perform the block. CTB block will be performed unilaterally on the ipsilateral side of surgery at the level of fourth rib. Group (C) (patient controlled analgesia): After successful extubation, patients will be transferred to PACU. Patients will receive a bolus dose of 5 mg nalbuphine then PCA pump in the form of 20 mg nalbuphine HCL in 100 ml 0.9% normal saline with basal rate of infusion 5ml/hr with self-administration bolus of 0.5ml with 15 min lock-out time.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 90
Est. completion date March 30, 2025
Est. primary completion date February 28, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: 1. American Society of Anaesthesiologists (ASA) Physical Status Class I, II. 2. Scheduled for modified radical mastectomy (MRM). 3. Body weight ranging from 60 to 100 kilograms. Exclusion Criteria: 1. Declining to give a written informed consent. 2. History of allergy to the medications used in the study. 3. Contraindications to regional anesthesia (including patient: refusal, coagulopathy, and local infection). 4. Psychiatric disorders. 5. Significant cognitive dysfunction. 6. American Society of Anesthesiologists (ASA) Physical Status Class III and IV. 7. Daily use of opioids. 8. Obesity (BMI > 35 kg/m2).

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
serratus anterior plane block
using ultrasound, 30 ml of bupivacaine 0.25% will be injected in the plane between the latissimus dorsi and serratus muscles
costotransverse block
using ultrasound, 30 ml of bupivacaine 0.25% will be injected in the costotransverse plane of fourth rib
patient controlled analgesia
PCA pump in the form of 20 mg nalbuphine HCL in 100 ml 0.9% normal saline with basal rate of infusion 5ml/hr. with self-administration bolus of 0.5ml with 15 min lock-out time.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

References & Publications (5)

Chappell AG, Bai J, Yuksel S, Ellis MF. Post-Mastectomy Pain Syndrome: Defining Perioperative Etiologies to Guide New Methods of Prevention for Plastic Surgeons. World J Plast Surg. 2020 Sep;9(3):247-253. doi: 10.29252/wjps.9.3.247. — View Citation

Holm UHU, Andersen CHS, Hansen CK, Tanggaard K, Borglum J, Nielsen MV. Ultrasound-guided multiple-injection costotransverse block for mastectomy and primary reconstructive surgery. A study protocol. Acta Anaesthesiol Scand. 2022 Mar;66(3):386-391. doi: 10.1111/aas.14018. Epub 2022 Jan 5. — View Citation

Liu X, Song T, Xu HY, Chen X, Yin P, Zhang J. The serratus anterior plane block for analgesia after thoracic surgery: A meta-analysis of randomized controlled trails. Medicine (Baltimore). 2020 May 22;99(21):e20286. doi: 10.1097/MD.0000000000020286. — View Citation

Shamim Seth U, Perveen S, Ahmed T, Kamal MT, Soomro JA, Murtaza Khomusi M, Kamal M. Postoperative Analgesia in Modified Radical Mastectomy Patients After Instillation of Bupivacaine Through Surgical Drains. Cureus. 2022 Apr 13;14(4):e24125. doi: 10.7759/cureus.24125. eCollection 2022 Apr. — View Citation

Zhao Y, Jin W, Pan P, Feng S, Fu D, Yao J. Ultrasound-guided transversus thoracic muscle plane-pectoral nerve block for postoperative analgesia after modified radical mastectomy: a comparison with the thoracic paravertebral nerve block. Perioper Med (Lond). 2022 Jul 27;11(1):39. doi: 10.1186/s13741-022-00270-3. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analogue Scale score at 0,6,12 and 24 hour post-operatively. visual analogue scale is a scale from 0 to 10, 0 represent no pain at all and 10 represent the worst pain Visual Analogue Scale score will be assessed at both rest and arm elevation 24 hour post-operative
Secondary The total dose of nalbuphine consumption is used postoperatively per patient rescue analgesia for 24. dose of nalbuphine consumed by patients 24 hour post-operative
See also
  Status Clinical Trial Phase
Completed NCT06005480 - Understanding Rebound Pain After Regional Anesthesia Resolution in Healthy Volunteers Phase 1
Completed NCT04565093 - Efficacy of iPACK After Unilateral TKA N/A
Recruiting NCT06074471 - Motor Sparing Supraclavicular Block N/A
Completed NCT03740815 - Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection N/A
Completed NCT02524652 - Local Infiltration Analgesia vs Adductor Canal Block for Analgesia After Anterior Cruciate Ligament Reconstruction Phase 4
Completed NCT03913429 - Ultrasound-guided Bilateral Suprazygomatic Maxillary Nerve Block and Bimaxillary Osteotomy N/A
Completed NCT05012332 - Local Anesthesia Spread After an Erector Spinae Plane Block. N/A
Withdrawn NCT04015284 - Intraoperative Pain and Quality of Surgical Block During Shoulder Surgery Assessed by NOL Index N/A
Recruiting NCT05432934 - Transversus Abdominis Plane Blocks With and Without Dexamethasone Phase 1/Phase 2
Recruiting NCT05512897 - Does ESP Block Reduce Pain and Opiates Consumption After Surgery N/A
Completed NCT04085263 - Rhomboid Intercostal and Subserratus Plane Block N/A
Not yet recruiting NCT04001387 - Feasibility of Real-time Ultrasound-guided Spinal Anesthesia Using Dynamic Needle Tip Positioning
Active, not recruiting NCT05478629 - Safety of Regional Anesthesia in Ukraine: the Survey
Terminated NCT03296033 - Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin Phase 4
Withdrawn NCT02603900 - Adductor Canal Catheter vs Local Infiltration of Analgesia for Total Knee Arthroplasty Phase 4
Completed NCT03666845 - Plasma Ropivacaine Concentrations After Sciatic Nerve Block in Patients With Chronic Kidney Disease
Completed NCT03394807 - LaGRA Trial in Laparoscopic Cholecystectomy Phase 4
Completed NCT05558449 - Impact of Virtual Reality Hypno-sedation on Functional Recovery and Anxiety in Foot Surgery With Regional Anesthesia Phase 4
Completed NCT02433561 - Intra- Versus Extraplexic Catheter Placement for Continuous Interscalene Brachial Plexus Block Phase 4
Recruiting NCT06147401 - Comparison of PENG Associated With LFCN Block Versus FICB for Multimodal Analgesic Management in THA N/A